nSpire Health Appoints Dr. Robert Crapo As Chairman of Scientific & Medical Advisory Board
nSpire Health announced today the recent appointment of Dr. Robert Crapo as chairman of its scientific and medical advisory board. Dr. Crapo has served on the National Heart and Lung’s Asthma Clinical Research Network Protocol Review Committee, has been a member of the American Thoracic Society Committee on proficiency standards for clinical pulmonary laboratories since 1983 until recently, and chaired the committee since 1993. He is medical director of the pulmonary laboratory at LDS Hospital in Salt Lake City, and the recipient of the 2006 distinguished scientist award from the American College of Chest Physicians.
Under Dr. Crapo’s chairmanship, the nSpire Health advisory board supports the company’s Strategic and Product Planning efforts providing a direct link between the company, clinicians, scientists, and other key opinion leaders in the cardio-pulmonary marketplace. Members of the board assist in developing the vision for products and services and evaluate the company’s emerging technologies. Board members directly develop clinical trial protocols for the world’s most prominent pharmaceutical companies and contribute to the company’s worldwide educational efforts.
“Dr. Crapo is an expert in the diagnosis and treatment of lung disease,” stated Michael Sims, President and CEO of nSpire Health. “His investigative research and numerous publications have defined normal values for pulmonary function testing and guidelines for pulmonary labs used around the world. Dr. Crapo’s experience in clinical trials research and his ability to assemble a world-class team of scientists and physicians will significantly contribute to our vision of revolutionizing the way the world detects and treats respiratory diseases.”
“I’m pleased to support nSpire Health’s vision for the future of cardiopulmonary health care and chair the scientific and medical advisory board,” Dr. Crapo said. “It is a valuable opportunity to bring together clinicians, patients, and industry in a partnership resulting in enhanced patient care.”
About nSpire Health
nSpire Health develops and manufactures respiratory care products and provides related services in over 100 countries. The company is focused on cardiopulmonary diagnostics, respiratory core lab services, and disease management solutions designed to improve health care productivity while increasing the overall quality of patient care. nSpire Health is the exclusive provider of PiKo(R) home health monitors and HDpft(TM) systems, the most accurate and precise pulmonary function testing systems worldwide.